昭衍新药：2025年净利润2.98亿元

Group 1 - The company, Zhaoyan New Drug, announced its 2025 annual report, revealing an operating income of 1.658 billion yuan, a year-on-year decrease of 17.87% [1] - The net profit attributable to shareholders of the listed company was 298 million yuan, showing a significant year-on-year increase of 302.08% [1]